GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abcam PLC (OTCPK:ABCZF) » Definitions » EV-to-FCF

Abcam (ABCZF) EV-to-FCF : -206.06 (As of May. 11, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Abcam EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Abcam's Enterprise Value is $5,294.5 Mil. Abcam's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 was $-25.7 Mil. Therefore, Abcam's EV-to-FCF for today is -206.06.

The historical rank and industry rank for Abcam's EV-to-FCF or its related term are showing as below:

ABCZF' s EV-to-FCF Range Over the Past 10 Years
Min: -369.38   Med: 45.4   Max: 147.53
Current: -206.06

During the past 13 years, the highest EV-to-FCF of Abcam was 147.53. The lowest was -369.38. And the median was 45.40.

ABCZF's EV-to-FCF is not ranked
in the Biotechnology industry.
Industry Median: 6.5 vs ABCZF: -206.06

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-11), Abcam's stock price is $22.25. Abcam's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.015. Therefore, Abcam's PE Ratio for today is 1,483.33.


Abcam EV-to-FCF Historical Data

The historical data trend for Abcam's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abcam EV-to-FCF Chart

Abcam Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Dec22
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.59 103.41 101.06 106.62 -238.33

Abcam Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Jun22 Dec22 Jun23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -238.33 -

Competitive Comparison of Abcam's EV-to-FCF

For the Biotechnology subindustry, Abcam's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abcam's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abcam's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Abcam's EV-to-FCF falls into.



Abcam EV-to-FCF Calculation

Abcam's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=5294.549/-25.694
=-206.06

Abcam's current Enterprise Value is $5,294.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Abcam's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 was $-25.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abcam  (OTCPK:ABCZF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Abcam's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=22.25/0.015
=1,483.33

Abcam's share price for today is $22.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Abcam's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.015.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Abcam EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Abcam's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Abcam (ABCZF) Business Description

Traded in Other Exchanges
N/A
Address
Discovery Drive, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AX
Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.